111 related articles for article (PubMed ID: 21844873)
1. Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission.
Chou WC; Peng KY; Lei WC; Ko BS; Tsay W; Kuo CH; Tien HF
Leukemia; 2012 Mar; 26(3):527-9. PubMed ID: 21844873
[No Abstract] [Full Text] [Related]
2. Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.
Takahashi K; Roh W; Zhang J; Propotopov A; Patel K; Strickland S; Kim A; Vnencak-Jones C; Pelletier S; Parmar S; Garcia-Manero G; Kornblau S; Chin L; Kantarjian H; Futreal PA; Ravandi F
Am J Hematol; 2015 Jul; 90(7):E134-5. PubMed ID: 25801490
[No Abstract] [Full Text] [Related]
3. Inhibition of mutant IDH1 in acute myeloid leukaemia.
Yaqub F
Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638561
[No Abstract] [Full Text] [Related]
4. [Study on NPM1 and IDH mutations in childhood acute myeloid leukemia].
Zhang L; Zeng HM; Ai XF
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):449-52. PubMed ID: 23688760
[No Abstract] [Full Text] [Related]
5. Therapeutic targeting of isocitrate dehydrogenase mutant AML.
Boddu P; Borthakur G
Expert Opin Investig Drugs; 2017 May; 26(5):525-530. PubMed ID: 28388242
[No Abstract] [Full Text] [Related]
6. Nucleophosmin gene mutation in acute myeloid leukemia patients.
Khorshied MM; Said WA; Shaaban HA
Saudi Med J; 2010 May; 31(5):582-4. PubMed ID: 20464055
[No Abstract] [Full Text] [Related]
7. [Prognostic factors of acute myeloid leukemia].
Inokuchi K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
[No Abstract] [Full Text] [Related]
8. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
9. 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
Pollyea DA; Kohrt HE; Zhang B; Zehnder J; Schenkein D; Fantin V; Straley K; Vasanthakumar A; Abdel-Wahab O; Levine R; Godley LA; Medeiros BC
Leuk Lymphoma; 2013 Feb; 54(2):408-10. PubMed ID: 22680765
[No Abstract] [Full Text] [Related]
10. NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation.
Raman HS; Shanmugam V; Li J; Steensma DP; Kim AS; Luskin MR
Leuk Lymphoma; 2021 Jul; 62(7):1790-1792. PubMed ID: 33586600
[No Abstract] [Full Text] [Related]
11. [Detection of the IDH1 gene mutation in acute myeloid leukemia by PCR-high resolution melting analysis].
Lin J; Qian J; Yao DM
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):484-6. PubMed ID: 22213873
[No Abstract] [Full Text] [Related]
12. [IDH gene mutations and acute myeloid leukemia].
Sun C; Zhang SJ; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):273-5. PubMed ID: 23683434
[No Abstract] [Full Text] [Related]
13. Enasidenib for relapsed/refractory acute myeloid leukemia with IDH2 mutations: optimizing the patient experience.
Roboz GJ
Clin Adv Hematol Oncol; 2018 May; 16(5):322-325. PubMed ID: 29851927
[No Abstract] [Full Text] [Related]
14. Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia.
Gupta C; Kaulfuss S; Görlich K; Othman B; Chaturvedi A; Heuser M
Ann Hematol; 2020 Jun; 99(6):1415-1417. PubMed ID: 32296913
[No Abstract] [Full Text] [Related]
15. Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing.
Andrulis M; Capper D; Luft T; Hartmann C; Zentgraf H; von Deimling A
Leuk Res; 2010 Aug; 34(8):1091-3. PubMed ID: 20227112
[TBL] [Abstract][Full Text] [Related]
16. IDH1 inhibitor shows promising early results.
Cancer Discov; 2015 Jan; 5(1):4. PubMed ID: 25583779
[TBL] [Abstract][Full Text] [Related]
17. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
[TBL] [Abstract][Full Text] [Related]
18. Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.
Jeziskova I; Razga F; Toskova M; Dvorakova D; Timilsina S; Mayer J; Racil Z
Leuk Lymphoma; 2013 Apr; 54(4):867-70. PubMed ID: 22950897
[No Abstract] [Full Text] [Related]
19. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
20. The cytological features of NPM1-mutated acute myeloid leukemia.
Bain BJ; Heller M; Toma S; Pavlů J
Am J Hematol; 2015 Jun; 90(6):560. PubMed ID: 25779376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
